New Research Confirms Hb Variant Test for Sickle Cell, Gazelle™, Useful for Screening and Tracking Treatment Management in Remote Settings, Advancing Doctors’ Abilities to Better Detect and Manage the Disease
June 20, 2024 08:00 ET
|
Hemex Health
PORTLAND, Ore. and ACCRA, Ghana, June 20, 2024 (GLOBE NEWSWIRE) -- Hemex Health announced that the results of two investigations into the effectiveness of their Gazelle™ point-of-care Hb Variant...
Health Monitor Network ® Appoints Senior VP, Rachel Ferrand, Accelerating Growth
June 18, 2024 08:50 ET
|
Health Monitor Network
Montvale,NJ, June 18, 2024 (GLOBE NEWSWIRE) -- Pioneering healthcare communications company, Health Monitor Network, today announced the appointment of Rachel Ferrand as Senior Vice President of...
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
June 03, 2024 08:00 ET
|
Avricore Health Inc.
Q1 2024 Results
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
April 04, 2024 07:30 ET
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Health Monitor Appoints Lorraine Forster as SVP, Human Resources, Galvanizing Growth
March 07, 2024 09:08 ET
|
Health Monitor Network
Montvale, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Pioneering healthcare communications company Health Monitor Network today announced the appointment of Lorraine Forster as Senior Vice President of...
Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
February 05, 2024 08:00 ET
|
Hemex Health
A clinical study demonstrated high accuracy for Hemex Health's beta thalassemia test. It is the only beta thal test for point of care.
Point of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partners
October 30, 2023 05:27 ET
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as...
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
September 15, 2023 12:53 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic...
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track
August 30, 2023 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to achieve significant growth, new partnerships and developing...
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
March 23, 2023 10:46 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching...